Measure 8 Ventures II

Measure 8 Ventures II is a venture capital fund managed by Measure 8 Venture Partners, a firm established in 2018 and based in New York, New York. The fund focuses on investments in the emerging U.S. and global cannabis industry, aiming to capitalize on the growth and opportunities within this sector. As a Registered Investment Adviser, Measure 8 Venture Partners seeks to leverage its expertise to identify and support promising ventures in the cannabis market.

Juan Pablo Martinez

Principal

Justin Ort

CEO and Portfolio Manager

Robert Sciarrone

Principal

6 past transactions

Bloomwell

Venture Round in 2023
The Bloomwell Group provides easy access to natural-based medicine and with a patient-centric D2C approach, it mainly focuses on a strong and revolutionizing streamlined customer journey. Bloomwell Group is focusing on the treatment of chronic diseases with significantly fewer side effects than conventional medicine.

Bloomwell

Seed Round in 2021
The Bloomwell Group provides easy access to natural-based medicine and with a patient-centric D2C approach, it mainly focuses on a strong and revolutionizing streamlined customer journey. Bloomwell Group is focusing on the treatment of chronic diseases with significantly fewer side effects than conventional medicine.

EMMAC Life Sciences

Convertible Note in 2020
EMMAC Life Sciences is a European medical cannabis company founded in 2018 and headquartered in London, England. It focuses on the cultivation, extraction, production, and distribution of cannabis-based products for medical applications. The company combines cutting-edge science and research with advanced cultivation techniques to develop unique supply and distribution partnerships across Europe. EMMAC aims to position itself as a thought leader in the research of medical cannabis benefits while establishing itself as a premier producer and supplier of medical cannabis, hemp, and derivative products. Its offerings are designed to support the healthcare community in treating patients with conditions such as chronic pain, spasticity, and cancer.

HERBL

Venture Round in 2019
HERBL is a cannabis supply chain company that helps brands and dispensaries grow and scale their businesses. The company brings together retailers and brands to make the process sustainable, scalable, and profitable. It provides comprehensive supply chain solutions through the utilization of proven distribution methods, the company's perishable supply chain strategy model emphasizes the importance of customer satisfaction. HERBL delivers solutions in curated retail services and inventory management to secure delivery and fulfillment. Michael Beaudry founded HERBL in 2016 and is headquartered in Santa Rosa, California.

Cura Partners

Venture Round in 2018
Cura Partners is a leading provider of cannabis oil, focusing on legal markets in the United States and internationally. The company specializes in offering high-quality Cannabidiol (CBD) extracted from industrial hemp, delivering products that emphasize purity, potency, and flavor. These offerings cater to individuals seeking the therapeutic benefits of cannabis without the psychoactive effects associated with Tetrahydrocannabinol (THC). Known for its commitment to innovation and high standards, Cura has established itself as a prominent brand on the West Coast, particularly in California and Oregon, while also expanding its presence in Nevada and other states. The company's mission is to redefine consumer expectations regarding cannabis products and to contribute to the ongoing legalization movement, which it views as a gateway to endless possibilities.

Curaleaf

Venture Round in 2017
Curaleaf is a leading vertically integrated medical and wellness cannabis operator.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.